Monte Rosa Therapeutics: Q3 Earnings Snapshot

BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $34.9 million in its third quarter.

The Boston-based company said it had a loss of 70 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE